GlaxoSmithKline Nigeria Plc released its financial results for nine months ended September 2015.
The result showed that revenue declined by 24.51% from N30.5 billion in Q3’2014 to N23 billion in Q3’2015.
Profit before tax also declined by 74.51% from N2.7 billion in Q3’2014 to N700 million in Q3’2015.
See Summary of result below..
|GlaxoSmithkline Nigeria Plc Q3 2015||2015||2014||% Change|
|Profit After Tax||485||1,848||-73.76%|
|Share Price (As at Press time)||38.20|